Ocular Therapeutix Inc.

NASDAQ: OCULHealthcare / Biotechnology / USA
4.65+0.0400+0.87%Vol 380 8301Y Perf -23.77%
Aug 21st, 2019 16:00
BID4.65 ASK4.66
Open4.68 Previous Close4.61
Pre-Market- After-Trading4.65
 - -%  - -%
Target Price
9.40 
Analyst Rating
Moderate Buy 1.60
Potencial %
102.15 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
+     32.20
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)219 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
46.37 
Earnings Date
7th Aug 2019

Today's Price Range

4.594.80

52wk Range

2.357.31

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Week
10.45%
1 Month
3.79%
3 Months
75.47%
6 Months
11.78%
1 Year
-23.77%
3 Years
-33.85%
5 Years
-69.79%
10 Years
-

Name / TickerPriceChg.Chg.%
OCUL4.650.04000.87
AAPL212.642.28001.08
GOOG1 191.258.56000.72
MSFT138.791.53001.11
XOM69.720.69001.00
WFC45.000.32000.72
JNJ131.530.93000.71
FB183.55-0.2600-0.14
GE8.16-0.2200-2.63
JPM107.610.30000.28
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.42-0.57-35.71
Q01 2019-0.42-0.45-7.14
Q04 2018-0.37-0.42-13.51
Q03 2018-0.36-0.38-5.56
Q02 2018-0.37-0.370.00
Q01 2018-0.39-0.40-2.56
Q04 2017-0.58-0.4424.14
Q03 2017-0.54-0.540.00
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.41-10.81Negative
12/2019 QR-0.37-15.63Negative
12/2019 FY-1.59-11.97Negative
12/2020 FY-0.94-22.08Negative
Next Report Date-
Estimated EPS Next Report-0.42
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume380 830
Shares Outstanding (in ths.)47 196
Trades Count1 275
Dollar Volume1 459 028
Avg. Volume675 012
Avg. Weekly Volume368 274
Avg. Monthly Volume538 049
Avg. Quarterly Volume903 265
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
3 (60.00 %)
4 (100.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.60
Moderate Buy
1.60
Strong Buy
1.00

Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application.

CEO: Antony C. Mattessich

Teplephone: +1 781 357-4000

Address: 15 Crosby Drive, Bedford 01730, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

42%58%

Bearish Bullish

52%48%

Bearish Bullish

49%51%

News